ACTABIO ApS: Financial statements 2024
CVR: 26025338
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
ACTABIO ApS (CVR 26025338) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -48,816 and a net result of DKK -76,814 compared with DKK -57,354 the year before. Equity in the 2024 report amounted to DKK -316,435.
- Revenue
- DKK 0
- Gross Profit
- DKK -48,816
- Profit/Loss
- DKK -76,814
- Equity
- DKK -316,435
- Total Assets
- DKK 30,847
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 0 | -49 t. | -77 t. | -316 t. | - |
| 2023 | 64 t. | 27 t. | -57 t. | -240 t. | - |
| 2022 | 22 t. | -22 t. | -92 t. | -182 t. | - |
| 2021 | 87 t. | 28 t. | -30 t. | -90 t. | - |
| 2020 | 127 t. | 55 t. | -25 t. | -60 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
ACTABIO ApS has published its annual report for 2023. Revenue came to DKK 64,250, and the net result was DKK -57,354.
About ACTABIO ApS
ACTABIO ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2001. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Finn Thyge Okkels. The company is owned by Finn Thyge Okkels. The company has 0 employees (2018). In 2025, the company reported revenue of DKK 12,375 and a net result of DKK -80,533 compared with DKK -76,814 the year before. Equity in the 2025 report amounted to DKK -396,968.